How do you pay?

How to pay the least

Ask for the cash price

Filkri

Filkri is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Filkri’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameFilkri
Authorized genericfilgrastim-laha
Regular genericfilgrastim-laha
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Filkri?
The original
–
–

Brand nameThe maker’s card

AccordCares Co-pay Assistance

Savings card from Accord BioPharma

Filkri’s maker has a savings program. Its page doesn’t list a dollar amount.

Sign up on filkrihcp.com 

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is Filkri itself, from the same company, sold without the brand name, and usually for less. For now Filkri is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Filkri is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

FILKRI is a leukocyte growth factor indicated to

  • Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever
  • Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML)
  • Reduce the duration of neutropenia and neutropenia-related clinical sequelae‚ e.g.‚ febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT)
  • Reduce the incidence and duration of sequelae of severe neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia
  • Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)

Source: the FDA label for Filkri (Accord BioPharma Inc.,), July 10, 2026. Full label on DailyMed 

Good to know